EU Clears AbbVie Takeover of Allergan Subject to Conditions EU Clears AbbVie Takeover of Allergan Subject to Conditions

The European Commission said on Friday it had approved U.S. drugmaker AbbVie's planned $63 billion acquisition of Botox-maker Allergan, subject to conditions.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Related Links:

Publication date: Available online 6 April 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Gordon Sussman, Jacques Hébert, Wayne Gulliver, Charles Lynde, William H. Yang, Kim Papp, Melinda Gooderham, Olivier Chambenoit, Sam Khalil, Frederica DeTakacsy, Antonio Vieira, Lenka Rihakova
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: Available online 6 April 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Elena Curto, Alfons Torrego, Noe Garin, Astrid Crespo-Lessmann, Vicente Plaza
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: Available online 6 April 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Dawn M. Angel, Robert S. Zeiger, Scott H. Sicherer, David A. Khan, Michael Schatz
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: April 2020Source: The Journal of Allergy and Clinical Immunology: In Practice, Volume 8, Issue 4Author(s):
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: April 2020Source: The Journal of Allergy and Clinical Immunology: In Practice, Volume 8, Issue 4Author(s): Mehran Alizadeh Aghdam, Fenne van den Broek, Feiko Rijken, Andre Cornelis Knulst, Heike Röckmann
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: April 2020Source: The Journal of Allergy and Clinical Immunology: In Practice, Volume 8, Issue 4Author(s): Saba Fekrvand, Reza Yazdani, Peter Olbrich, Andrew Gennery, Sergio D. Rosenzweig, Antonio Condino-Neto, Gholamreza Azizi, Hosein Rafiemanesh, Gholamreza Hassanpour, Nima Rezaei, Hassan Abolhassani, Asghar Aghamohammadi
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: April 2020Source: The Journal of Allergy and Clinical Immunology: In Practice, Volume 8, Issue 4Author(s): Allison Ramsey, Mary L. Staicu
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: April 2020Source: The Journal of Allergy and Clinical Immunology: In Practice, Volume 8, Issue 4Author(s): Diane R. Gold, Joanne E. Sordillo, Brent A. Coull
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: April 2020Source: The Journal of Allergy and Clinical Immunology: In Practice, Volume 8, Issue 4Author(s): Maykol Postigo, Chase S. Hall, Mario Castro
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: April 2020Source: The Journal of Allergy and Clinical Immunology: In Practice, Volume 8, Issue 4Author(s): Mariana C. Castells, James T. Li
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
More News: Allergy | Botox | Health | Mergers and Aquisitions | Primary Care